Scott Solomon
Harvard University
H-index: 190
North America-United States
Top articles of Scott Solomon
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping | Matthew G Dimond Nasrien E Ibrahim Mona Fiuzat John JV McMurray JoAnn Lindenfeld | 2024/3/1 | |
ELECTRONIC NUDGES TO INCREASE INFLUENZA VACCINATION UPTAKE AMONG PARTICIPANTS WITH HISTORY OF ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM NUDGE-FLU | Journal of the American College of Cardiology | Ankeet Bhatt Niklas Dyrby Johansen Daniel Modin Brian Claggett Safia Chatur | 2024/4/2 |
Effects of high‐dose versus standard‐dose quadrivalent influenza vaccine among patients with diabetes: A post‐hoc analysis of the DANFLU‐1 trial | Diabetes, Obesity and Metabolism | Mats C Højbjerg Lassen Niklas Dyrby Johansen Daniel Modin Joshua Nealon Sandrine Samson | 2024/5 |
Angiotensin receptor-neprilysin inhibition in patients with STEMI vs NSTEMI | The Journal of Heart and Lung Transplantation | S Alishetti GM Mondellini L Braghieri A Javaid KL Antler | 2020/4/1 |
Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy | JACC: Heart Failure | Veraprapas Kittipibul Muthiah Vaduganathan Uchechukwu Ikeaba Karen Chiswell Javed Butler | 2024/4/6 |
Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4 | Journal of Cardiac Failure | Ahmad Masri Mark V Sherrid Theodore P Abraham Lubna Choudhury Pablo Garcia-Pavia | 2024/3/15 |
High‐Dose vs. Standard‐Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data | Clinical Pharmacology & Therapeutics | Mehdi NajafZadeh HoJin Shin Sebastian Schneeweiss Shirley V Wang Scott D Solomon | 2024/1 |
Efficacy And Safety Of Sacubitril/valsartan In Patients Hospitalized With Heart Failure: A Prespecified, Pooled Individual Patient-level Analysis Of PIONEER-HF And PARAGLIDE-HF | Journal of Cardiac Failure | David A Morrow Eric Velazquez Akshay Desai Adam DeVore Serge Lepage | 2024/1/1 |
Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction | Journal of the American College of Cardiology | Alberto Foà Muthiah Vaduganathan Brian L Claggett Maria A Pabon Henri Lu | 2024/3/25 |
Natural language processing for adjudication of heart failure in a multicenter clinical trial: a secondary analysis of a randomized clinical trial | JAMA cardiology | Jonathan W Cunningham Pulkit Singh Christopher Reeder Brian Claggett Pablo M Marti-Castellote | 2024 |
Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial | JAMA cardiology | Orly Vardeny Akshay S Desai Pardeep S Jhund James C Fang Brian Claggett | 2024/1/24 |
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the … | Journal of the American Heart Association | Ankeet S Bhatt Muthiah Vaduganathan Brian L Claggett Ian J Kulac Inder S Anand | 2024/2/23 |
Effects of High-Dose vs. Standard-Dose Quadrivalent Influenza Vaccine Among Patients with Diabetes: A Post-Hoc Analysis of the DANFLU-1 Trial | Journal of the American College of Cardiology | Mats Lassen Niklas Dyrby Johansen Daniel Modin Joshua Nealon Matthew Loiacono | 2024/4/2 |
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT | International Journal of Cardiology | João Pedro Ferreira Brian L Claggett Jiankang Liu Abhinav Sharma Akshay S Desai | 2024/2/1 |
EFFECTS OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK | Journal of the American College of Cardiology | Safia Chatur Brian Claggett Finnian Mc Causland Milton Packer Akshay S Desai | 2024/4/2 |
OBESITY AND ADVERSE CARDIAC REMODELING IN HFPEF: THE PARAGON-HF TRIAL | Journal of the American College of Cardiology | Xiaowen Wang John Ostrominski Sheldon E Litwin Maja Cikes Bela Merkely | 2024/4/2 |
IMPACT OF PATISIRAN ON OUTPATIENT HEART FAILURE WORSENING IN PATIENTS WITH CARDIAC TRANSTHYRETIN AMYLOIDOSIS: RESULTS FROM THE APOLLO-B TRIAL | Journal of the American College of Cardiology | Marianna Fontana Mathew S Maurer Julian David Gillmore Shaun Bender Patrick Y Jay | 2024/4/2 |
Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial | JAMA cardiology | Ravi B Patel Frank E Silvestry Jan Komtebedde Scott D Solomon Gerd Hasenfuß | 2024/4/17 |
Tricuspid regurgitation and clinical outcomes in heart failure with reduced ejection fraction | Heart Failure | Marianna Adamo Marco Metra Brian L Claggett Zi Michael Miao Rafael Diaz | 2024/3/1 |
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER | JACC: Heart Failure | Jawad H Butt Pardeep S Jhund Kieran F Docherty Brian L Claggett Muthiah Vaduganathan | 2024/4/3 |